H. B. Fuller (NYSE:FUL) Announces Quarterly Earnings Results

H. B. Fuller (NYSE:FUL) announced its quarterly earnings data on Wednesday. The specialty chemicals company reported $1.41 EPS for the quarter, beating the consensus estimate of $1.37 by $0.04, Zacks reports. The business had revenue of $950.27 million during the quarter, compared to analysts’ expectations of $924.83 million. H. B. Fuller had a net margin of 5.29% and a return on equity of 12.29%. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the business posted $1.18 EPS. H. B. Fuller updated its FY 2026 guidance to 4.600-4.900 EPS.

H. B. Fuller Stock Performance

FUL opened at $61.94 on Friday. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.92 and a quick ratio of 1.15. The firm has a fifty day moving average price of $61.60 and a 200 day moving average price of $61.28. H. B. Fuller has a 1 year low of $48.71 and a 1 year high of $68.63. The stock has a market cap of $3.38 billion, a P/E ratio of 20.44, a P/E/G ratio of 0.85 and a beta of 0.96.

H. B. Fuller Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, May 14th. Stockholders of record on Thursday, April 30th were issued a dividend of $0.245 per share. This is a positive change from H. B. Fuller’s previous quarterly dividend of $0.23. The ex-dividend date of this dividend was Thursday, April 30th. This represents a $0.98 annualized dividend and a dividend yield of 1.6%. H. B. Fuller’s payout ratio is presently 32.34%.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Raymond James Financial set a $67.00 target price on shares of H. B. Fuller in a report on Friday. JPMorgan Chase & Co. raised shares of H. B. Fuller from an “underweight” rating to a “neutral” rating and set a $58.00 price target on the stock in a report on Wednesday, May 27th. Wall Street Zen raised H. B. Fuller from a “hold” rating to a “buy” rating in a research report on Sunday, March 29th. Royal Bank Of Canada set a $58.00 price objective on H. B. Fuller in a research note on Wednesday, May 27th. Finally, Vertical Research raised H. B. Fuller from a “hold” rating to a “strong-buy” rating in a report on Friday, March 27th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $66.50.

Key Stories Impacting H. B. Fuller

Here are the key news stories impacting H. B. Fuller this week:

• Positive Sentiment: H. B. Fuller reported second-quarter results that beat expectations, with EPS of $1.41 versus $1.37 consensus and revenue of $950.27 million versus $924.83 million estimated. The company also raised its FY2026 EPS guidance to $4.60-$4.90, supporting the case that core operations remain healthy. Article Title
• Neutral Sentiment: The company’s updated outlook was close to Wall Street’s expectations, which may limit how much of a positive reaction investors assign to the earnings beat alone.
• Negative Sentiment: Sentiment was pressured by H. B. Fuller’s agreement to buy Advanced Medical Solutions in a cash deal valued at about £715 million ($942 million), a transaction some investors view as aggressive and likely to add integration and financing risk. Article Title
• Negative Sentiment: Ancora publicly criticized the acquisition, calling it reckless and accusing management of ignoring shareholder opposition, which adds governance uncertainty and could weigh on the stock. Article Title
• Negative Sentiment: Investors are also digesting a new 10-K risk disclosure flagging “material emerging risks,” which can raise concerns about future volatility and execution risk. Article Title

Insider Buying and Selling

In other H. B. Fuller news, CEO Celeste Beeks Mastin bought 5,170 shares of the company’s stock in a transaction dated Tuesday, April 7th. The shares were purchased at an average cost of $57.08 per share, for a total transaction of $295,103.60. Following the transaction, the chief executive officer directly owned 8,670 shares of the company’s stock, valued at approximately $494,883.60. The trade was a 147.71% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 1.83% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Strs Ohio acquired a new position in shares of H. B. Fuller during the first quarter valued at approximately $101,000. EverSource Wealth Advisors LLC increased its position in shares of H. B. Fuller by 129.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,218 shares of the specialty chemicals company’s stock worth $73,000 after purchasing an additional 688 shares in the last quarter. Baird Financial Group Inc. increased its position in shares of H. B. Fuller by 19.6% during the second quarter. Baird Financial Group Inc. now owns 7,518 shares of the specialty chemicals company’s stock worth $452,000 after purchasing an additional 1,232 shares in the last quarter. Marshall Wace LLP raised its stake in H. B. Fuller by 382.1% in the 2nd quarter. Marshall Wace LLP now owns 20,370 shares of the specialty chemicals company’s stock valued at $1,225,000 after purchasing an additional 16,145 shares during the last quarter. Finally, Cerity Partners LLC raised its stake in H. B. Fuller by 2.3% in the 2nd quarter. Cerity Partners LLC now owns 11,499 shares of the specialty chemicals company’s stock valued at $692,000 after purchasing an additional 261 shares during the last quarter. 95.93% of the stock is owned by hedge funds and other institutional investors.

H. B. Fuller Company Profile

H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.

Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.